Bacillus Calmette-Guérin vaccination, thymic size, and thymic output in healthy newborns

Pediatr Res. 2017 Jun;81(6):873-880. doi: 10.1038/pr.2017.27. Epub 2017 Feb 3.

Abstract

Background: The Bacillus Calmette-Guérin vaccine (BCG) has been associated with beneficial nonspecific effects on infant health. We aimed to examine the effect of BCG at birth on thymic size and the associations between thymic output, circulating lymphocytes, risk of infection, and thymic size.

Methods: In infants randomized to BCG or no BCG, thymic index (TI), and thymic/weight index (TWI) were measured by ultrasound at birth and at the age of 3 mo. T cell subpopulations including CD4+ T cells, CD8+ T cells, and recent thymic emigrants (RTEs) were assessed by flow cytometry. Infections up to age 3 mo were parent-reported.

Results: BCG vaccination did not affect thymic size at age 3 mo, measured as TI. At birth, the number of lymphocytes, CD4+ T cells, CD8+ T cells, and RTEs were positively associated with TI and TWI. Furthermore, a reduced risk of infections up to age 3 mo was associated with a large thymic size at birth.

Conclusion: We found no effect of BCG vaccination on thymic size. The positive association between thymic output, lymphocytes, reduced risk of infections, and TI/TWI suggests that assessment of TI/TWI by ultrasound may be a predictor of the immunological capacity in the newborn.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • B-Lymphocyte Subsets
  • BCG Vaccine / administration & dosage*
  • Female
  • Flow Cytometry
  • Humans
  • Infant, Newborn
  • Male
  • T-Lymphocyte Subsets
  • Thymus Gland / anatomy & histology*
  • Thymus Gland / diagnostic imaging
  • Thymus Gland / physiology

Substances

  • BCG Vaccine